Introduction
============

The blood-brain barrier (BBB) is a specialized structure in the central nervous system (CNS) that consists of cerebral capillary endothelial cells, basal lamina and glial processes [@B1]-[@B3]. These layered cell structures are critical for maintaining brain homeostasis by forming tight junctions with low permeability to control the passage of molecules between the blood and brain parenchyma [@B3], [@B4]. However, the BBB also hinders transport of therapeutic agents such as drugs, genes or antibodies from blood into brain tissue, thus lowering treatment efficiency [@B5], [@B6]. Burst-tone focused ultrasound (FUS) exposure in the presence of microbubbles (MBs) has been shown to transiently open the BBB to allow free penetration of therapeutic molecules into the brain. Due to its unique strengths to change BBB integrity in a noninvasive, transient, and localized manner, FUS-induced BBB opening has been recognized as a potentially promising approach for brain drug delivery [@B7], [@B8].

Several *in vivo* imaging techniques have been used to detect FUS-induced BBB opening. Among them, the most consistent and reliable approach has been to intravenously (i.v.) inject an imaging contrast agent followed by detection of the contrast change by magnetic resonance imaging (MRI). For example, some of the first experiments involved administration of gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA; 937 Da) for the detection of BBB opening by contrast-enhanced T1-weighted MRI [@B7], [@B8]. Magnetic nanoparticles have also been used to monitor FUS-induced BBB opening by T2- or T2\*-weighted MRI [@B9]-[@B11]. When using Gd-DTPA or magnetic nanoparticles, the concentration of leaked contrast agent can be accurately quantitated by measuring spin-spin or spin-lattice relaxivity [@B11], [@B12]. Dynamic contrast-enhanced (DCE)-MRI with compartment modeling was also recently used to evaluate contrast agent kinetics and the change in CNS permeability after induction of BBB opening [@B13], [@B14]. Other methods besides MRI have been used to detect FUS-induced BBB opening, such as single photon emission computed tomography (SPECT) with i.v. administration of ^99m^TC-DTPA radiotracer as the contrast agent, or small-animal photoacoustic imaging with gold nanorods [@B15], [@B16]. In addition, dynamic changes in microvasculature during FUS-induced BBB opening have been microscopically observed by fluorescent multi-photon microscopy, and with a high-speed camera [@B17], [@B18].

Ultrasound has long been utilized for diagnostic and imaging purpose. Using ultrasound to monitor FUS-induced BBB opening provides several advantages including no requirement for radiation or compatibility concerns, and high temporal resolution which allows real-time monitoring. Furthermore, therapeutic and imaging ultrasound excitations can be integrated into a single ultrasound platform with overlapping aperture and intrinsically co-localized setup. Goertz *et al.* first attempted monitoring FUS-induced BBB opening by determining the time-intensity curve (TIC) change of concurrent clinical ultrasound imaging (9-17 MHz) [@B19]. Unfortunately, this study did not provide strong evidence of a correlation between FUS-induced BBB opening and the TIC. We similarly reported that BBB opening could not be successfully monitored by ultrasound imaging (25 MHz) in a small-animal model, although red blood cell (RBC) extravasations were detectable in real-time under excessive applied pressure [@B20]. Under these conditions, the RBCs provided sufficient backscattered signal for contrast-enhanced ultrasound imaging. A major reason for the failure of contrast-enhanced ultrasound imaging in monitoring FUS-induced BBB opening is that MBs are designed to be in the micrometer size range to maximize their echogenic capability. Their large size limits the location of MBs to the vascular/ microvascular system, and they do not leak into CNS parenchyma. MB-enhanced ultrasound imaging to detect FUS-induced BBB opening is thus intrinsically challenging.

An alternative may be provided by monitoring the dynamics of MB destruction-replenishment (D/R), which was originally developed for measuring perfusion kinetics in ultrasound imaging. High ultrasound pressure can cause destruction of i.v. administered, circulating MBs within the imaging zone. The resulting transient drop in signal as well as the dynamics of signal re-appearance can be deduced from the ultrasound imaging TIC. These MB D/R dynamics are known to be highly correlated with vascular dynamics and perfusion kinetics. Wei *et al.* first proposed the use of MB D/R to quantify myocardial blood flow [@B21]. In 2001, Rim *et al.* pioneered the use of MB D/R to estimate changes in cerebral microvascular blood volume and mean MB velocity in an *in vivo* animal model [@B22]. Since local FUS-induced BBB opening involves a change in vascular blood-brain permeability, the dynamics of local blood flow may also be affected, suggesting the possibility of using the ultrasound-imaging D/R approach to monitor FUS-induced BBB opening.

The aim of this study was therefore to evaluate whether MB D/R-based perfusion kinetics could be used to monitor FUS-induced BBB opening by ultrasound imaging. We hypothesized that FUS-induced BBB opening induced a change in perfusion kinetics, and the measurement of this change by ultrasound imaging could reflect the success in monitoring of FUS-induced BBB opening.

Materials and Methods
=====================

MB Destruction-Replenishment (D/R) Model
----------------------------------------

Previous studies suggested that blood flow and vasculature dynamics can be evaluated by MB disruption and replenishment, using a growing mono-exponential model or sigmoid function approximation [@B21], [@B23]-[@B25]. Yeh *et al.* subsequently proposed a modified sigmoid function to improve the estimation precision from the TIC (Figure [1](#F1){ref-type="fig"}(a)) [@B26]. The replenishment cycle is estimated from the received ultrasound B-mode signal using a modified sigmoid function, as follows:

where *R*(*t*) is the received intensity after replenishment of MBs following time (*t*); *A* is the echo intensity of steady state (i.e., refilled MBs); *α* is the rate constant of the sigmoidal function which is proportional to the mean blood flow velocity; and *c* is the time interval from the start to the inflection point in the sigmoid curve.

Replenishment with intact MBs is assumed to begin at the boundary of the -6 dB ultrasound beam width (i.e., *E*/2) of the imaging probe. The time-intensity relationship corresponds to the inflection point of the sigmoidal function when the concentration of MBs is restored to 50% in the sample volume (i.e., at the *t*~1~time point). The slope of the TIC increases with time before the inflection point because of the increasing intensity of the ultrasound beam, and decreases thereafter. The flow velocity (*v*) can be estimated as (*E*/2)/*c*. The tangent slope at the inflection point (*t* = *c*) can be described as (*Aα*)/4. As shown in Figure [1](#F1){ref-type="fig"}(a), the slope is also equal to (*A*/2)/*c*, and then *c* = 2/*α*. The blood flow velocity can then be written as (*α/4*) *E*. When *E* is a constant, a linear relationship between the blood flow kinetics which is characterized by rate constant *α*(with the unit of s^-1^) can be expected [@B26].

Signal Processing and *α* Map Creation
--------------------------------------

A two-dimensional (2-D) map of the *α* distribution was created to identify the change in MB replenishment intensity, and thus assess the vascular perfusion kinetic change. The intensities of MB signals in D/R images were obtained by averaging all of the pixels within the region of interest (ROI) using a sliding window, and was presented over time to construct the TICs of MBs (Figure [1](#F1){ref-type="fig"}(b)). To reduce the interference of noise on TICs, we used an integrated TIC technique to reduce the effect of *α*variability on the blood flow estimation [@B26]. The integrated TICs were fitted using the built-in nonlinear least algorithm of MATLAB (MathWorks Inc., MA, USA) (Figure [1](#F1){ref-type="fig"}(c)), and rate constant *α*maps were created by calculating the *α* values from TICs of each pixel (Figure [1](#F1){ref-type="fig"}(d)). The *α* values were expected to be proportional to the flow velocity, therefore the rate constant *α*maps should display the corresponding flow velocity distribution. Finally, the rate constant *α*map acquired before FUS sonication was subtracted from that obtained after sonication to derive a rate constant *α*-change map.

Preparation of MBs
------------------

MBs were prepared by the thin-film hydration method [@B20]. For a 1 mL formulation, 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC) (Avanti Polar Lipids, AL, USA) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-\[methoxy(polyethyleneglycol)-2000\] (DSPE-PEG-2000) (Avanti Polar Lipids) were mixed at a molar ratio of 6:1 in chloroform, dried for over 24 h under reduced pressure with a rotary evaporator (Rotavapor R‐210, Büchi Labortechnik AG, Flawil, Switzerland) to form a lipid-film, and stored at -20°C. To prepare the aqueous lipid solution, the film was hydrated with 5 μL/mL glycerol phosphate-buffered saline (PBS, pH 7.4) and the gas was replaced with perfluoropropane (C~3~F~8~). Finally, the solution was intensely shaken by an agitator for 45 s to obtain the MB suspension. The MBs were counted and sized using a coulter counter equipped with a 30 μm sensor orifice (Multisizer 3, Beckman Coulter, Miami FL, USA) for a 0.7-20 μm range. The mean size and concentration of MBs were 1.18 ± 0.01 μm and (35.74 ± 0.49) × 10^9^MB/mL (post MBs preparation 30 min, 37°C), respectively. ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S1-S2).

Animal Preparation
------------------

The experimental protocol of this study was approved by the Institutional Animal Care and Use Committee of National Tsing Hua University and adhered to the experimental animal care guideline (IACUC approval number: NTHU10044). A total of 28 pathogen-free adult male Sprague-Dawley rats (300-350 g) were anesthetized by chloral hydrate (400 mg/kg). Before the start of an experiment, rats were subjected to craniotomy and venous cannulation. The cranial window (nearly 10 mm × 4 mm) was created with a high-speed drill to reduce attenuation and distortion of the ultrasound beam. The catheter was placed into the jugular venous arch for injection of MBs and Evans Blue (EB) dye during experiments.

In-House Built High Frequency Ultrasound Imaging /FUS Sonication Platform and Experiments
-----------------------------------------------------------------------------------------

The integrated platform consisted of a single-element circular-aperture FUS transducer with a hole in its center for the ultrasound imaging transducer. The outer transducer was spherically-focused annulus with a central frequency of 2 MHz and a -*6 dB* fractional bandwidth of 83.9% (model V3966, Panametrics, MA, USA; outer element size = 26.1 mm, inner element size = 9.9 mm, focal length = 26.8 mm), providing the high power energy needed to both destroy MBs (0.3-1.0 MPa; burst length = 10 cycles; PRF = 4000 Hz; exposure time = 0.5 s; mechanical index: 0.21-0.71) and generate the excitation pulse for BBB opening (0.5/0.7 MPa; burst length = 2000 cycles; PRF = 1 Hz; exposure time = 60 s; mechanical index: 0.35/0.50). The FUS transducer was driven by a function generator (HP 33120, Hewlett-Packard, TX, USA) through a power amplifier (A150, E&I, NY, USA). The electric impedance within the transducer was matched to the output impedance of the power amplifier by an external impedance-matching circuit.

The inner transducer was customized to have a central frequency of 40 MHz with a -*6 dB* fractional bandwidth of 94% (element size = 3 mm, focal length = 9 mm) for acquiring ultrasound B-mode images. The arbitrary waveform generator (AWG-2040, Tektronix, CA, USA) provided 3 cycle 40 MHz sinusoid excitation through the power amplifier (325LA, Electronic Navigation Inc., NY, USA) to the imaging transducer. The acoustic pressure of 40 MHz imaging pulse was 2.4 MPa (mechanical index = 0.38). To prevent echoes from the destruction pulses from reaching the imaging transducer, a delay generator (DG-535, Stanford Research system, CA, USA) was used for separating imaging and destruction into two backscattered echo signals. Radio-frequency (RF) echoes were received using the same transducer through a diplexer circuit (model DIP-3, Matec Instruments NDT, MA, USA). The received RF echoes were magnified by the preamplifier (model AU-1114, MITEQ Inc., NY, USA), digitized at a sampling rate of 400 Msamples/s by the PC-based 12-bit analog-to-digital board (model CS12400, Gage Applied Tech Inc., IL, USA), and stored in a PC for generating B-mode images with MATLAB.

To achieve uniform MB destruction throughout the entire imaging plane, the 2 MHz FUS and 40 MHz imaging transducers were positioned together on the piezoelectric-type motor and mechanical scanning was performed (stepping resolution = 8 μm, traveling distance = 3 mm, lead transmission speed = 27.5 mm/s). These settings were equivalent to eight imaging frames per second with a traveling time of 0.125 s for each imaging region, and the FUS exposure covering the entire imaging region (Detailed imaging and FUS exposure parameters are listed in [Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Table S1). The pressures reported in this study were calculated by measuring the peak-rarefactional pressure amplitudes with a polyvinylidene-difluoride-type (PVDF) hydrophone (model HGL-0085, ONDA, Sunnyvale, CA, USA; calibration range = 1-40 MHz) in a tank filled with distilled and degassed water.

The reliability of MB D/R to estimate perfusion kinetics was tested *in vitro* with a vessel-phantom and *in vivo* in rat brain via the in-house built high frequency ultrasound imaging system ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S3) [@B26]. The vessel was constructed by embedding a polyethylene tube with an outer diameter of 1 mm before the phantom solidified and removing it immediately after. The phantom was prepared from 2 g of agarose powder (UltraPure^TM^ Agarose, CA, USA) in 100 mL of water. The solidified phantom was immersed in a tank filled with degassed water. The flow rate of the flow chamber was set to 6 mL/hr (i.e., 1.58 mm/s mean velocity) with a syringe pump (KDS100, KD Scientific, PA, USA). The MBs were diluted 2000 times with 0.9 % normal saline.

The feasibility of our proposed method to *in vivo* monitor FUS-induced rat cerebral perfusion kinetic changes (*N* = 3) at each time point (before and 5 s after BBB opening) was primarily tested using the same integrated platform for ultrasound imaging and FUS sonication. The center of the FUS focal zone was placed at 3.5 mm posterior and 2.5 mm lateral to the bregma (left brain), and 3 mm below the skull surface (cerebral cortex). During the experiments, the MBs were diluted 2000 times with 0.9 % normal saline and injected into the rats by syringe pump with a constant flow rate of 10 mL/hr (i.e., 2.63 mm/s mean velocity). The total infusion time was 8 min. The total infusion volume was 1.3 mL. In order to remove brain tissue signals, the acquired B-mode images were subtracted from the image obtained without MBs injection. The subtracted images were used to construct TIC curves and calculate the *α* values for each ROIs and eventually create the *α* maps.

Commercial Ultrasound Imaging System and FUS Sonication Setup
-------------------------------------------------------------

The major *in vivo* animal experiments were conducted by using a high frame rate commercial ultrasound imaging system ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S4(a)**;**Vevo2100, VisualSonics, Toronto, Canada;). The B-mode images were obtained by the imaging system via a 21-MHz linear array transducer (MS250, VisualSonics) (power: 5%; frame rate: 30 fps; lateral resolution: 165 μm). MB destruction was also carried out with this imaging system by operation in contrast mode with a destruction burst at 100% power. BBB opening was conducted with the same 2 MHz FUS transducer (Detailed sonication and imaging parameters are listed in [Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Table S2). The two transducers were arranged in parallel, separated by approximately 49 mm using an in-house made holder which ensured that the foci of the FUS beam and the 21 MHz imaging beam were fixed at the same depth. The holder was mounted on a three-dimensional (3-D) motion stage. Animals were randomly divided into three groups: (1) Control group without FUS exposure (*N* = 7); (2) 0.5 MPa FUS exposure (burst length = 1 ms, PRF = 1 Hz, exposure time = 60 s, mechanical index= 0.35; *N* = 9); and (3) 0.7 MPa FUS exposure (same exposure conditions as group 2, mechanical index= 0.50; *N* = 9).

Prior to FUS exposure to induce BBB opening, a D/R image series (frame rate = 30 fps, acquisition time = 20 s; power = 5%) was acquired, with the imaging transducer also serving to destroy MBs (10 cycle short burst excitation for 2 s; power = 100%). Afterwards, the process of BBB opening was conducted (at this time, the FUS transducer was repositioned, within a minute, to the target site by the 3-D motion stage). Three series of D/R images were then acquired at 60, 90 and 120 s after BBB opening. MBs were perfused by the syringe pump with a flow rate of 10 mL/hr to obtain D/R images at each time point. The total infusion time was 8 min and the infusion volume was 1.3 mL. In TIC estimation, B-mode images subtracted by baseline (image before MB injection) were performed to feature out MB-related signal intensity change. The estimated TICs were then employed to estimate the corresponding *α* values (described in above section of Signal Processing and *α* Map Creation). Detailed experimental time line of the *in vivo* animal experiments is shown in [Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S4 (b).

MRI Verification
----------------

After conducting FUS-induced BBB opening and D/R sequence acquisition, animals were repositioned in the MR scanning bore for MRI (7T, ClinScan 70/30 USR, Bruker; time lapse controlled to be less than 5 min after FUS exposure), with immediate bolus administration of Gd-DTPA (Agnevist, Bayer Healthcare, 0.5 ml/kg). DCE-MRI was performed to calculate MR permeability maps by acquiring a 3-D FLASH T1-weighted sequence (TE/TR = 0.76 ms/ 2.31 ms; slice thickness = 0.8 mm; flip angles = 50º/ 200º; matrix size = 192 × 132; acquisition time = 10 min; number of slices = 6; FOV = 34 × 40 mm). Permeability information was obtained based on data post analysis using the Extended-Kety model to generate blood-brain permeability mapping (i.e., Ktrans mapping) [@B27].

Histological Examination
------------------------

EB dye (100 mg/kg; 960 Da; forms a 67 kDa complex with serum albumin) was administered 5 min prior to the process of BBB opening, to verify its success. Animals were sacrificed 10 min after completing the experimental procedure, and perfused with 0.9% normal saline via the left cardiac ventricle until colorless perfusion fluid appeared from the right atrium. The brain tissues were removed, and fixed with 10% neutrally buffered formalin (Sigma-Aldrich) followed by embedding in optimal cutting temperature compound (Tissue-Tek OCT, Sakura Finetek Inc., Torrance, CA, USA) and stored at -50°C. Histological brain sections were obtained with a Cryostat Microtome at a slice thickness of 10 μm in the same direction as ultrasound imaging. BBB opening was identified by the leakage of EB dye into brain tissues. Hematoxylin and eosin (H&E) staining was applied to confirm the presence of erythrocyte extravasations.

Statistical Analysis
--------------------

Results are presented as the mean and standard deviation of the mean (error bars) of at least three independent samples. All statistical evaluations were carried out with unpaired two-tailed Student\'s *t*-tests. A *p*-value of less than 0.05 was considered to be statistically significant for data-pair comparisons.

RESULTS
=======

*In Vitro*Ultrasound Imaging Optimization for MB D/R Modeling
-------------------------------------------------------------

We first tested the reliability of FUS-induced MB D/R*in vitro*. Typical B-mode imaging contrast changes during the MB D/R period, and the corresponding mean TIC responses, are shown in Figures [2](#F2){ref-type="fig"}(a) and (b), respectively. After estimating the perfusion kinetics, the MB D/R kinetics can be represented by mapping the rate constant *α* (Figure [2](#F2){ref-type="fig"}(c)). In this case, the sliding window was fixed to be 115 × 115 μm to estimate *α* from the curve-fitted integrated TIC of the sliding window. This allowed estimation of the 2-D *α* map. The measured mean rate constant *α* in this example was (1.0 ± 0.2) s^-1^. In addition, the laminar flow effect of MBs could be observed: the *α* value was larger in the inner than the outer region of the tube, implying a higher MB perfusion rate in the tube center, and decreased perfusion caused by the viscosity of the tube shell. This correlated with traditional physical flow phenomena [@B28], and confirmed the qualitative correctness of our perfusion kinetics estimation. Thus, the rate constant *α* map could potentially be used to observe flow and perfusion changes in a small-animal brain. We also confirmed that employed MBs during FUS-induced D/R phase can provide stable and satisfactory TIC estimated quality for the following analyses (see [Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S5).

To gain information for the design of further experiments, we measured the MB activity in response to MB-destroying FUS excitation. MBs started to present apparent broadband emissions at excitation pressures higher than 0.5 MPa, and reached their resonant peak when the pressure was increased to 1.0 MPa ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S6; for comparison, the tube phantom containing only perfused water did not yield acoustic harmonic emissions). A further increase in ultrasound pressure (\>1.2 MPa) led to an inverse reduction in MB resonant activity, implying that the majority of the MBs were directly disrupted by the initial ultrasound excitation cycle. This *in vitro* experiment confirmed that MBs were destroyed at 0.5-1.6 MPa. Within this range of pressure levels, acoustic cavitation (including stable and inertial cavitation) and immediate MB disruption are expected to occur in different proportions, depending on the exact excitation pressure level.

Next we evaluated the acoustic pressure which was required to sufficiently characterize perfusion kinetics. The efficiency of MB destruction reached (55.8 ± 3.2)%, (65.5 ± 6.6)%, and (84.2 ± 2.3)% at excitation pressures of 0.3, 0.4, and 0.5 MPa, respectively, and 90% of MBs were destroyed at 0.6 MPa (Figure [3](#F3){ref-type="fig"}(a); burst length = 10 cycles, PRF = 4000 Hz, exposure time = 0.5 s, mechanical index = 0.42). In addition, a stable drop in TIC (Figure [3](#F3){ref-type="fig"}(b)) and a consistent and stable value for the estimated rate constant *α* (Figure [3](#F3){ref-type="fig"}(c)) could be acquired at an ultrasound excitation pressure of 0.5 MPa.

We also investigated whether TIC dynamics were affected by flow perfusions or MB concentration ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figures S7 (a) and (b)). The estimated rate constant *α* was found to be sensitive to flow perfusion rate variations from 0.53 to 2.63 mm/s, which mimicked microvascular flow *in vivo*. This effect suggested that rate constant *α* could be used for precise prediction of the perfusion fluid velocity. Estimation of rate constant *α* was found to be sufficiently robust and independent of MB concentration at the range of 10^5^ to 10^6^ bubbles/mL in circulation (Supplemental Figure S7(c)).

*In Vivo*Ultrasound Imaging Mapping of MB-FUS-Induced BBB Opening
-----------------------------------------------------------------

Our characterization of *in vitro* perfusion kinetics provided important information for optimizing the *in vivo* experimental protocol. An ultrasound pressure of 0.6 MPa was expected to induce a sufficiently high rate of MB destruction to produce stable TIC dynamics and allow estimation of the rate constant *α*. We further verified that FUS exposure reaching 0.5 MPa (burst length = 2000 cycles; PRF = 1 Hz; exposure time = 60 s; mechanical index = 0.35) induced a BBB opening effect in a small animal ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S8), and we demonstrated that MB-destroying emission (0.6 MPa, burst length = 10 cycles; PRF = 4000 Hz; exposure time = 0.5 s; mechanical index = 0.42) did not induce any changes in BBB integrity ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S9). Therefore, the MB destruction pressure was chosen as 0.6 MPa, whereas the BBB opening pressure of the FUS inducer was selected to be 0.5/ 0.7 MPa.

A typical *in vivo* animal experiment for comparison of TICs between FUS-exposed and control normal brain tissues is shown in Figure [4](#F4){ref-type="fig"}. An in-house built ultrasound imaging and FUS sonication platform was used, with the MB destruction area covering the whole observed brain area (detailed ultrasound specifications provided in [Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Table S1). Regions subjected to BBB opening revealed distinct TIC dynamics compared to the unexposed region. The moderately BBB opening region (region 2) had delayed MB re-perfusion dynamics, whereas the heavy BBB opening region (region 1) presented a further retardation in re-perfusion dynamics compared to control (region 3). The rate constant α dropped significantly from its original value of 3.35 s^-1^ for the control to 1.1 s^-1^and 0.19 s^-1^ in the moderately and heavily BBB opening regions, respectively. We concluded that ultrasound-observed MB reperfusion dynamics could be used to successfully distinguish BBB opening status from TIC response.

Next we attempted high resolution, window-by-window (window size = 825 ×825 μm) analysis of the rate constant *α*-change map (defined as the difference in the rate constant *α* before and after FUS-induced BBB opening), using a commercial ultrasound imaging system and FUS sonication setup. Typical results from animal experiments including the EB stained regions and the rate constant *α*-change map are shown in Figure [5](#F5){ref-type="fig"}. We did not detect any remarkable changes in rate constant *α*-change map in the control animal group (Figure [5](#F5){ref-type="fig"}(a)). In contrast, a 0.5 MPa exposure successfully created localized BBB opening (Figures [5](#F5){ref-type="fig"}(b) and (c); ROI enlarged 2× or 4×, respectively), and the estimated rate constant *α*-change maps correlated well with the BBB opening regions from stained brain sections. Histological examination indicated that a 0.5 MPa exposure did not induce gross pathological changes after inducing BBB opening ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S10), whereas a 0.7 MPa exposure created a more profound BBB opening effect and EB penetration (Figures [5](#F5){ref-type="fig"}(d) and (e)), but also occasionally induced scattered RBC extravasations at the FUS exposure site (detailed occurrence of RBC extravasation induced by 0.5 and 0.7 MPa FUS exposures was shown in [Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S11).

We considered that the time lapse between FUS-induced BBB opening and MB destruction may also influence the stability of the estimated perfusion kinetics due to variations in the circulating MB concentration, and should therefore be evaluated. Three consecutive MB D/R processes were performed after FUS exposure, and the change in rate constant *α* was evaluated ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S12; 60s, 90s, and 120s after FUS exposure). The 0.5 MPa exposure induced a (46.5 ± 3.0)% *α*-value change for different time lapse intervals, whereas the 0.7 MPa exposure induced an *α*-value change from (57.74 ± 7.26)% with a moderate further change to (68.72 ± 6.8)% over time. Thus changes in rate constant *α* induced by FUS-induced BBB opening were relative stable and consistent at different time lapse intervals, without a significant influence on the perfusion kinetic measurements. Moreover, changes in *α* induced by 0.5 and 0.7 MPa were significantly different (with *p* \< 0.05), implying that the scale of induced BBB opening could potentially be inferred from the magnitude of the change in rate constant *α*. The movies showing the commercial 21 MHz ultrasound (Vevo 2100) MB D/R images, corresponding TICs, and *α*-change map before (Video S1) and after (Video S2) 2 MHz FUS exposure with pressures of 0.5 and 0.7 MPa (60 s after FUS exposure) are shown in Supporting Information.

Correlation of *In Vivo* Ultrasound-Monitoring and MRI Detection of BBB Opening
-------------------------------------------------------------------------------

To verify the reliability and accuracy of MB D/R mapping from ultrasound imaging to monitor BBB opening, we carried out DCE-MRI on the same experimental animals. Typical results from one control, two 0.5 MPa exposures, and two 0.7 MPa exposures are shown as CE-T1 MR images (to illustrate the signal intensity change due to Gd-DTPA leakage), MR Ktrans mapping (to show kinetic change of blood-to-brain permeability), and estimated ultrasound rate constant *α*-change maps in Figure [6](#F6){ref-type="fig"}. Control animals showed no contrast changes in CE-T1 MR images, MR Ktrans mapping, or ultrasound rate constant *α*-change maps (Figure [6](#F6){ref-type="fig"}(a)). BBB opening was induced near the cortical surface of the left hemisphere by 0.5 MPa exposure, and could be clearly detected in both CE-T1 MR images and MR Ktrans distributions (Figures [6](#F6){ref-type="fig"}(b) and (c)). The corresponding ultrasound rate constant *α*-change map showed a change in contrast at the exposure site, which was co-localized with the MRI signal. A relatively higher contrast change at the left cortical/sub-cortical region was observed for the 0.7 MPa exposure compared to the 0.5 MPa exposure based on CE-T1 MR images and MR Ktrans mapping. The ultrasound rate constant *α*-change map also revealed a change in contrast that was highly correlated with the MR signal (Figures [6](#F6){ref-type="fig"}(d) and (e)). Notably, the ultrasound rate constant *α*-change maps presented a distinct increase in signal from (8.2 ± 0.3) dB to (15.6 ± 0.5) dB for the 0.5 and 0.7 MPa exposures, respectively.

The correlation of the ultrasound rate constant *α*-change map with either MR Ktrans mapping or the CE-T1 MR signal change was analyzed (Figure [7](#F7){ref-type="fig"}). There was a better correlation between α-change mapping and MR Ktrans mapping than between the rate constant *α*-change map and the CE-T1 MR signal intensity change (*R*^2^ = 0.84 and 0.76, respectively; Figures [7](#F7){ref-type="fig"}(a) and 7(c)). The true-positive (*TP*), false negative (*FN*), and false positive (*FP*) rates were (89.5 ± 4.8)%, (12.6 ± 5.4)%, and (40.1 ± 12.9)%, respectively for Ktrans mapping (Figure [7](#F7){ref-type="fig"}(b)). In other words, when using MR Ktrans mapping as the benchmark, the precision of ultrasound rate constant *α*-change mapping reached 87.6% (defined as *TP*/(*TP*+*FN*)×100%) with sensitivity up to 69.1% (defined as *TP*/(*TP*+*FP*)×100%). On the other hand, if using CE-T1 MR signal intensity change as the benchmark, the *TP*, *FN*, and *FP* rates were (87.6 ± 5.3)%, (15.5 ± 4.8)%, and (68.8 ± 12.5)%, respectively, so that the precision and detection sensitivity were 84.9% and 56%, respectively (Figure [7](#F7){ref-type="fig"}(d)).

Discussion
==========

In this study, we presented the use of MB D/R modeling to monitor changes in BBB integrity. Specifically, we evaluated the use of rate constant *α*-change mapping to monitor FUS-induced BBB opening. Our data indicated that rate constant *α*-change mapping could indeed provide high detection sensitivity and precision, and was highly correlated with monitoring via MRI. To our knowledge, this is the first demonstration of the successful application of ultrasound imaging to detect FUS-induced BBB opening. Since diagnostic ultrasound has intrinsic benefits including its high temporal resolution and convenience by virtue of being integrated with therapeutic ultrasound, we believe that ultrasound-based detection of FUS-induced BBB opening can provide a useful and valuable alternative to other detection methods in the clinical application of FUS brain drug delivery.

The MB D/R technique was originally developed to estimate the perfusion of various organs including heart, kidney, liver, and also CNS [@B21], [@B28]-[@B30]. In this study, we confirmed that the technique can also be applied to monitor FUS-induced BBB opening. This implies that the process of FUS-induced BBB opening correlates with changes in blood flow/ perfusion at the FUS-exposed brain tissues and that this effect persist even 120s after FUS sonication. We previously demonstrated induction of a shortage in blood supply after FUS-induced BBB opening [@B20]. In addition, fluorescence multi-photon microscopy was recently applied for real-time monitoring of the dynamics of fluorescent dye leakage caused by FUS-induced BBB opening [@B18], [@B32]. FUS exposure appears to cause capillaries to experience mechanical stress, thus inducing transient vasoconstrictions and changes in local perfusion. Our real-time fluorescent microscopy observations confirmed that FUS exposure at either 0.5 or 0.7 MPa pressure resulted in vasoconstriction of MB-containing capillaries ([Additional file 1](#SM1){ref-type="supplementary-material"}: Supplemental Figure S13), similar to previous reports based on multi-photon microscopy [@B18], [@B32]. We therefore hypothesized that vasoconstrictions triggered by FUS exposure in the presence of MBs induce transient changes in blood flow, so that ultrasound perfusion kinetics can be used as an indirect and possibly quantitative index to reflect FUS-induced BBB opening.

The mechanism whereby MB-associated FUS excitation induces transient BBB opening is thought to primarily involve widening of tight junctions due to endothelial cell deformation [@B32], [@B33]. Ultrasound excitation induces repetitive MB contraction/ expansion within the lumen of the vessel, causing radial propagation of a mechanical wave from the oscillating bubble cloud. The resulting local changes in intra-lumen pressure then induce shear stress on the adjacent capillary lumen wall, finally inducing endothelial cell deformation and loosening of tight junctions. A number of studies have observed that shear stress on the capillary wall can trigger potassium ions (K^+^) release from calcium-activated potassium channels on the endothelial cell membrane, leading to cortical spreading depression (CSD) [@B18], [@B34]. Gursoy-Ozdemir *et al.* confirmed that CSD can alter the integrity of the BBB by inducing overexpression of brain matrix metalloproteinases (MMPs) [@B35]. Our findings appear to support previous reports of a major role of vasoconstriction of capillaries on the observed endothelial cell deformation.

We found that ultrasound perfusion kinetic change mapping technology could be successfully used to monitor the FUS-induced BBB opening process. However, we note that our study had a number of limitations. First, all animals in this study were subjected to a craniotomy (with skull bone thickness of \~1 mm) prior to FUS exposure (2 MHz in this study) and ultrasound imaging (40/21 MHz in this study). This modification posts a challenge when intending to translate the imaging approach to a clinical setting. Human cranial bone thickness is typically 10 mm and clinical ultrasound imaging frequency ranges from 5-10 MHz. One possibility to overcome this limitation is to further decrease the operating frequency to similar or even lower than the frequency range of a transcranial Doppler device (2 MHz). In addition, Oreilly *et al.* recently reported installation of a number of wide-band PVDF hydrophones which co-localized with the hemispherical ultrasound phased array element to allow reception of passive acoustic emission during FUS-induced BBB opening process [@B36]. Notwithstanding their work only allowed one measurement at the focus point of FUS and not to image, their system could potentially also be applied with our proposed scheme for BBB opening. Second, the rate constant *α*-change map was obtained from perfusion kinetics measured prior to and after FUS exposure. Although the change observation from rate constant *α*-change mapping was identical to current contrast-enhanced imaging approaches, neither method can currently provide monitoring of FUS-induced BBB opening with a referenceless manner. Third, MBs had to be administered multiple times, which is inconvenient. Thus a future improvement of our approach would be to perform the MB D/R process together with MB administration for FUS exposure, as previously suggested [@B19]. Finally, only very acute BBB permeability change (\~2 min after FUS sonication) can be detected by our proposed method due to the effect of vasoconstriction would recover with time. Raymond *et al.* showed that FUS-induced brain vessel vasoconstriction persisted as long as 5 min (frequency = 1.029 MHz; burst length = 10000 cycles; PRF = 1 Hz; acoustic pressure = 0.2 MPa; exposure time = 45 s; mechanical index = 0.2) [@B18]. Fan *et al.* demonstrated that FUS-induced cerebral blood-supply shortage would recover within 2 h (frequency = 1 MHz; burst length: 10000 cycles; PRF = 1 Hz; exposure time = 60 s; acoustic power = 1.1 MPa; mechanical index = 1.1) [@B20]. In conclusion, we proposed the use of ultrasound perfusion kinetic mapping to monitor FUS-induced BBB opening. We demonstrated that the results from this approach correlated highly with the predicted outcome obtained from MRI, with sufficiently high detection sensitivity and precision. Ultrasound imaging has intrinsic benefits including high temporal resolution, accessibility, and compatibility for integration with therapeutic ultrasound. Our approach provides a new opportunity to pursue ultrasound-monitored FUS-induced BBB opening, and could be a potentially valuable alternative for estimating the distribution of drug delivery.
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![(a) Conceptual diagrams of MB D/R approach for monitoring FUS-induced BBB opening. (b) Sequentially acquired ultrasound B-mode images. (c) TIC obtained from a specific ROI of B-mode images and estimation of rate constant *α* value. (d) Corresponding rate constant *α*-mapping distribution.](thnov04p1014g001){#F1}

![Typical *in vitro* phantom experiment to demonstrate ultrasound perfusion kinetic modeling using the MB D/R approach. (a) Consecutive ultrasound B-mode images of a tube phantom (inner diameter of tube = 1 mm; imaging frequency = 40 MHz; MB destruction frequency = 2 MHz with pressure of 0.6 MPa). (b) Corresponding mean TIC obtained from the inner tube region as a ROI. (c) Established rate constant *α*-mapping distribution.](thnov04p1014g002){#F2}

![*In vitro* phantom experiment to evaluate the influence of pressure of MB destruction on the estimation of kinetic parameters. (a) Efficiency of MB destruction at different acoustic pressures. (b) TIC response at different acoustic pressures. (c) Variation in rate constant *α*-value estimation at different acoustic pressures.](thnov04p1014g003){#F3}

![Typical *in vivo* animal experiment to estimate the TIC response and corresponding kinetic parameter rate constant *α* distribution within the selected regions (1: Heavy BBB opening region at the FUS exposure center; 2: mild BBB opening region at the FUS exposure peripheral; 3: normal tissue without FUS exposure). (a) Upper: whole EB dye brain section; lower: 4× enlarged. (b) Corresponding B-mode images after MBs destruction (corresponding to the lower panel of (a)). (c) Corresponding TIC responses at the three selected regions and the estimated *α* values. Arrow: BBB-opening region.](thnov04p1014g004){#F4}

![EB-stained brain sections (upper: original; middle: 2× / 4× enlarged) and corresponding rate constant *α*-change map distributions (bottom panels; 2× / 4× enlarged) to evaluate FUS-induced BBB opening in left hemisphere. (a) Control; (b) and (c) FUS exposure pressure of 0.5 MPa; (d) and (e) FUS exposure pressure of 0.7 MPa. Arrow: BBB-opening region.](thnov04p1014g005){#F5}

![Comparison of MRI-based detection (upper panels: CE-T1 MR images; 2^nd^ and 3^rd^ panels: MR Ktrans map, original and 2× / 4× enlarged) and rate constant *α*-change map (bottom panels; 2× / 4× enlarged) of FUS-induced BBB opening. (a) Control. (b) and (c) FUS exposure pressure of 0.5 MPa. (d) and (e) FUS exposure pressure of 0.7 MPa. Arrow: BBB-opening region.](thnov04p1014g006){#F6}

![(a) and (b) Correlation and the corresponding occurrence of true-positive (*TP*), false negative (*FN*), and false positive (*FP*) when comparing rate constant *α*-change map distribution to MR Ktrans map. (c) and (d) Correlation and the corresponding occurrence of *TP*, *FN*, and *FP* when comparing rate-constant *α*-change map distribution to CE-T1 MR images.](thnov04p1014g007){#F7}
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